Versican and brevican are expressed with distinct pathology in neonatal hypoxic-ischemic injury

Journal of Neuroscience Research

Volumn 86, Issue 5, 2008, Pages 1106-1114

  Leonardo, Christopher C ^a   Eakin, Autumn K ^a   Ajmo, Joanne M ^a   Gottschall, Paul E ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Chondroitin sulfate proteoglycans; Developmental disorders; Hypoxia ischemia; Oligodendrocytes; Rat

Indexed keywords

BREVICAN; GLIAL FIBRILLARY ACIDIC PROTEIN; LECTICAN; PROTEOCHONDROITIN SULFATE; SULFATIDE; UNCLASSIFIED DRUG; VERSICAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CELL DAMAGE; CONTROLLED STUDY; CORPUS STRIATUM; GRAY MATTER; HEMISPHERE; HIPPOCAMPAL FIMBRIA; IMMUNOREACTIVITY; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; WHITE MATTER;

ANIMALS; ANIMALS, NEWBORN; BRAIN; BRAIN INFARCTION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPOXIA-ISCHEMIA, BRAIN; LECTINS, C-TYPE; NERVE FIBERS, MYELINATED; NERVE TISSUE PROTEINS; NEUROGLIA; PROTEOCHONDROITIN SULFATES; RATS; RATS, SPRAGUE-DAWLEY; RIBULOSE-BISPHOSPHATE CARBOXYLASE; STEM CELLS; SULFOGLYCOSPHINGOLIPIDS; VERSICANS;

EID: 41149145708     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21553     Document Type: Article

References (35)

1. Arvin KL, Han BH, Du Y, Lin SZ, Paul SM, Holtzman DM. 2002. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 52(1):54-61.
2. Asher RA, Morgenstern DA, Fidler PS, Adcock KH, Oohira A, Braistead JE, Levine JM, Margolis RU, Rogers JH, Fawcett JW. 2000. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J Neurosci 20:2427-2438.
3. Asher RA, Morgenstern DA, Shearer MC, Adcock KH, Pesheva P, Fawcett JW. 2002. Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J Neurosci 22:2225-2236.
4. Ashwal S, Pearce WJ. 2001. Animal models of neonatal stroke. Curr Opin Pediatr 13:506-516.
5. Aya-ay J, Mayer J, Eakin AK, Muffly BG, Anello M, Sandy JD, Gottschall PE. 2005. The effect of hypoxic-ischemic brain injury in perinatal rats on the abundance and proteolysis of brevican and NG2. Exp Neurol 193(1):149-162.
6. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ. 1998. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 18:6241-6253.
7. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL, Holtzman DM. 2002. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 22:455-463.
8. Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC. 2001. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 21:1302-1312.
9. Beggah AT, Dours-Zimmermann MT, Barras FM, Brosius A, Zimmermann DR, Zurn AD. 2005. Lesion-induced differential expression and cell association of neurocan, brevican, versican V1 and V2 in the mouse dorsal root entry zone. Neuroscience 133:749-762.
10. Craig A, Ling Luo N, Beardsley DJ, Wingate-Pearse N, Walker DW, Hohimer AR, Back SA. 2003. Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human. Exp Neurol 181:231-240.
11. Elibol B, Soylemezoglu F, Unal I, Fujii M, Hirt L, Huang PL, Moskowitz MA, Dalkara T. 2001. Nitric oxide is involved in ischemia-induced apoptosis in brain: a study in neuronal nitric oxide synthase null mice. Neuroscience 105(1):79-86.
12. Ferriero DM, Holtzman DM, Black SM, Sheldon RA. 1996. Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol Dis 3(1):64-71.
13. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE. 2000. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 20:9235-9241.
14. Galtrey CM, Fawcett JW. 2007. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Brain Res Rev 54:1-18.
15. Gottschall PE, Sandy JD, Zimmerman DR. 2005. Substrates for metalloendopeptidases in the central nervous system. In: Conant C, Gottschall PE, editors. Matrix Metalloproteinases in the Central Nervous System. London: Imperial College Press. p 87-118.
16. Hamrick SE, Ferriero DM. 2003. The injury response in the term newborn brain: can we neuroprotect? Curr Opin Neurol 16(2):147-154.
17. Jaworski DM, Kelly GM, Hockfield S. 1999. Intracranial injury acutely induces the expression of the secreted isoform of the CNS-specific hyaluronan-binding protein BEHAB/brevican. Exp Neurol 157:327-337.
18. Jian Liu K, Rosenberg GA. 2005. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic Biol Med 39(1):71-80.
19. Jones LL, Margolis RU, Tuszynski MH. 2003a. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol 182:399-411.
20. Jones LL, Sajed D, Tuszynski MH. 2003b. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition. J Neurosci 23:9276-9288.
21. Levine S. 1960. Anoxic-ischemic encephalopathy in rats. Am J Pathol 36:1-17.
22. Mayer J, Hamel MG, Gottschall PE. 2005. Evidence for proteolytic cleavage of brevican by the ADAMTSs in the dentate gyrus after excitotoxic lesion of the mouse entorhinal cortex. BMC Neurosci 6:52.
23. Morgenstern DA, Asher RA, Fawcett JW. 2002. Chondroitin sulphate proteoglycans in the CNS injury response. Prog Brain Res 137:313-332.
24. Ogawa T, Hagihara K, Suzuki M, Yamaguchi Y. 2001. Brevican in the developing hippocampal fimbria: differential expression in myelinating oligodendrocytes and adult astrocytes suggests a dual role for brevican in central nervous system fiber tract development. J Comp Neurol 432:285-295.
25. Reynolds R, Hardy R. 1997. Oligodendroglial progenitors labeled with the O4 antibody persist in the adult rat cerebral cortex in vivo. J Neurosci Res 47:455-470.
26. Rezaie P, Dean A. 2002. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology 22(3):106-132.
27. Rice JE 3rd, Vannucci RC, Brierley JB. 1981. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9(2):131-141.
28. Shalak L, Perlman JM. 2004. Hypoxic-ischemic brain injury in the term infant-current concepts. Early Hum Dev 80(2):125-141.
29. Silver J, Miller JH. 2004. Regeneration beyond the glial scar. Nat Rev Neurosci 5(2):146-156.
30. Skoff RP, Bessert DA, Barks JD, Song D, Cerghet M, Silverstein FS. 2001. Hypoxic-ischemic injury results in acute disruption of myelin gene expression and death of oligodendroglial precursors in neonatal mice. Int J Dev Neurosci 19(2):197-208.
31. Towfighi J, Zec N, Yager J, Housman C, Vannucci RC. 1995. Temporal evolution of neuropathologic changes in an immature rat model of cerebral hypoxia: a light microscopic study. Acta Neuropathol (Berl) 90:375-386.
32. Vannucci RC, Connor JR, Mauger DT, Palmer C, Smith MB, Towfighi J, Vannucci SJ. 1999. Rat model of perinatal hypoxic-ischemic brain damage. J Neurosci Res 55(2):158-163.
33. Volpe JJ. 2001. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 50:553-562.
34. Vorisek I, Hajek M, Tintera J, Nicolay K, Sykova E. 2002. Water ADC, extracellular space volume, and tortuosity in the rat cortex after traumatic injury. Magn Reson Med 48:994-1003.
35. Yamaguchi Y. 2000. Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 57:276-289.